Shenzhen Kexing Pharmaceutical Co., Ltd.
6 clinical trials · Sponsor
◉ Watch Shenzhen Kexing Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| To Evaluate the Safety, Pharmacokinetics, and Efficacy of GB10 Intravitreal Injection in Patients With Neovascular Age-related Macular Degeneration (nAMD) (NCT07406438) | Shenzhen Kexing Pharmaceutical Co., Ltd. | 2026-02-12 |
| To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of GB18 Injection in Healthy Participants (NCT07237464) | Shenzhen Kexing Pharmaceutical Co., Ltd. | 2025-10-28 |
| Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency (NCT07126288) | Shenzhen Kexing Pharmaceutical Co., Ltd. | 2025-08-31 |
| Study Evaluating SHEN26 Capsule in Patients With Mild to Moderate COVID-19 (NCT05908071) | Shenzhen Kexing Pharmaceutical Co., Ltd. | 2023-05-13 |
| Study of SHEN26 Capsule in Patients With Mild to Moderate COVID-19 (NCT05676073) | Shenzhen Kexing Pharmaceutical Co., Ltd. | 2022-12-08 |
| A Phase I Study of SHEN26 Capsule in Healthy Participants (NCT05504746) | Shenzhen Kexing Pharmaceutical Co., Ltd. | 2022-08-08 |
Track Shenzhen Kexing Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.